Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties

Progress in Lipid Research

Volumn 42, Issue 6, 2003, Pages 463-478

  Moghimi, S M ^a   Szebeni, J ^b  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; MACROGOL; NANOPARTICLE;

ADSORPTION; EVALUATION; HUMAN; MACROPHAGE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; STEREOCHEMISTRY; THEORETICAL STUDY;

EID: 0141927263     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7827(03)00033-X     Document Type: Review

References (75)

1. Moghimi S.M., Hunter A.C., Murray J.C. Pharmcol Rev. 53:2001;283-318.
2. Moghimi S.M., Hunter A.C. Trend Biotechnol. 18:2000;412-420.
3. Woodle M.C., Lasic D.D. Biochim Biophys Acta. 1113:1992;171-199.
4. Monfardini C., Veronese F.M. Bioconjugate Chem. 9:1998;418-450.
5. deGennes P.G. Adv. Colloid Interface Sci. 27:1987;189-209.
6. Moghimi S.M., Muir I.S., Illum L., Davis S.S., Kolb-Bachofen V. Biochim Biophys Acta. 1179:1993;157-165.
7. Lasic D.D., Martin F.J., Gabizon A., Huang S.K., Papahadjopoulos D. Biochim Biophys Acta. 1070:1991;187-192.
8. Leon S.L., Lee J.H., Andrade J.D., de Gennes P.G. J Colloid Interface Sci. 142:1991;149-166.
9. Torchilin V.P., Omelyanenko V., Papisov M.I., Bogdanov A.A. Jr., Trubetskoy V.S., Herron D.I.N.et al. Biochim Biophys Acta. 1195:1994;11-20.
10. Papisov M.I. Adv Drug Deliv Rev. 32:1998;119-138.
11. Dams E.T., Laverman P., Oyen W.J., Storm G., Scherphof G.L., van der Meer J.W.et al. J Pharmcol Exp Ther. 292:2000;1071-1079.
12. Laverman P., Brouwers A.H., Dams E.T., Oyen W.J., Storm G., van Rooijen N.et al. J Pharmcol Exp Ther. 293:2000;996-1001.
13. Laverman P., Boerman O.C., Oyen W.J.G., Corstens F.H.M., Storm G. Crit Rev Ther Drug Carr Syst. 18:2001;551-566.
14. Moghimi S.M., Gray T. Clin Science. 93:1997;371-379.
15. Moghimi S.M. Clin Science. 95:1998;389-391.
16. Moghimi S.M., Hedeman H., Christy N.M., Illum L., Davis S.S. J Leukoc Biol. 54:1993;513-517.
17. Moghimi S.M., Murray J.C. J Natl Cancer Inst. 88:1996;766-768.
18. Laverman P., Carstens M.G., Storm G., Moghimi S.M. Biochim Biophys Acta. 1526:2001;227-229.
19. Moghimi S.M., Hunter A.C. Crit Rev Ther Drug Carr Syst. 18:2001;527-550.
20. Szebeni J., Baranyi L., Savay S., Lutz H.U., Jelezarova E., Bunger R.et al. J Liposome Res. 10:2000;467-481.
21. Szebeni J., Baranyi L., Savay S., Milosevits J., Bunger R., Laverman P. et al. J Liposome Res. 12:2002;165-172.
22. Price M.E., Cornelius R.M., Brash J.L. Biochim Biophys Acta. 1512:2001;191-205.
23. Szebeni J. Crit Rev Ther Drug Carr Syst. 18:2001;567-606.
24. Allen T.M. Trend Pharmacol Sci. 15:1994;215-220.
25. Gabizon A.A., Muggia F.M. Woodle M.C., Storm G. Long circulating liposomes: old drugs, new therapeutics. 1998;155-174 Springer-Verlag and Landes Bioscience.
26. Allen T.M., Hansen C., Martin F., Redemann C., Yang-Young A. Biochim Biophys Acta. 1066:1991;29-36.
27. Utkhede D.R., Tilcock C.P. J Liposome Res. 8:1998;537-550.
28. Woodle M.C., Matthay K.K., Newman M.S., Hidayat J.E., Collins L.R., Redemann C.et al. Biochim Biophys Acta. 1105:1992;193-200.
29. Laverman P., Corstens F.H., Boerman O.C., Dams E.T., Oyen W.J., van Rooijen N.et al. J Pharmacol Exp Ther. 298:2001;607-612.
30. Chonn A., Semple S.C., Cullis P.R. J Biol Chem. 267:1992;215-222.
31. Semple S.C., Chonn A., Cullis P.R. Biochemistry. 35:1995;2521-2525.
32. Semple S.C., Chonn A., Cullis P.R. Adv Drug Deliv Rev. 32:1998;3-17.
33. Blunk T., Hochstrasser D.F., Sanchez J.C., Muller B.W., Muller R.H. Electrophoresis. 14:1993;1382-1387.
34. Norman ME, Williams P, Illum L. Biomaterials 1992;14:193-202.
35. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S.et al. Colloid Surf B-Biointerf. 18:2000;301-313.
36. Gref R., Domd A., Quellec P., Blunk T., Muller R.H., Verbavatz J.M.et al. Adv Drug deliv Rev. 16:1995;215-233.
37. Stolnik S., Daudali B., Arien A., Whetstone J., Heald C.R., Garnett M.C.et al. Biochim Biophys Acta. 1514:2001;261-279.
38. Luck M., Schoder W., Paulke B.R., Blunk T., Muller R.H. Electrophoresis. 20:1999;2063-2068.
39. Peracchia M.T., Harnisch S., Pinto-Alphandary H., Gulik A., Dedieu J.C., Desmaele D.et al. Biomaterials. 20:1999;1269-1275.
40. Elwing H., Askendal A., Lundstorm I. J Biomed Mater Res. 21:1987;1023-1028.
41. Cuypers P.A., Willems G.M., Hemker H.C., Hermens W.T. Ann NY Acad Sci. 516:1987;244-252.
42. Rapoza R.J., Horbett T.A. Poly Mater Sci Eng. 59:1988;249-252.
43. Slack S.M., Horbett T.A. ACS Symp. Ser. 602:1995;129-137.
44. Bradley A.J., Devine D.V., Ansell A.M., Janzen J., Brooks D.E. Arch. Biochem. Biophys. 357:1998;185-194.
45. Szebeni J, Baranyi L, Savay S, Milosevits J, Bodo M, et al. Method Enzymol [in press].
46. Szebeni J., Fontana J.L., Wassef N.M., Mongan P.D., Morse D.S., Dobbins D.E.et al. Circulation. 99:1999;23022-23309.
47. Szebeni J., Baranyi B., Savay S., Bodo M., Morse D.S., Basta M.et al. Am. J. Physiol. 279:2000;H1319-H1328.
48. Mosqueira V.C.F., Legrand P., Gulik A., Bourdon O., Gref R., Labarre D. Biomaterials. 22:2001;2967-2979.
49. Gbadamosi J.K., Hunter A.C., Moghimi S.M. FEBS Lett. 532:2002;338-344.
50. Smith C.A., Vogel C.V., Muller-Eberhard H.J. J Biol Chem. 257:1982;9879-9882.
51. Chonn A., Cullis P.R., Devine D.V. J Immunol. 146:1991;4234-4241.
52. Moghimi S.M., Hunter A.C. Pharmaceut Res. 18:2001;1-8.
53. Szebeni J. Crit Rev Ther Drug Carr Syst. 15:1998;57-88.
54. Lutz H.U., Stammler P., Jelezarova E., Nater M., Spath P.J. Blood. 88:1996;184-193.
55. Bradley A.J., Test S.T., Murad K.L., Mitsuyoshi J., Scott M.D. Transfusion. 41:2001;1225-1233.
56. Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos, D. Pharmacol Rev 51; 1999:691-743.
57. Wilkinson B.J., Peterson P.K., Quie P.G. Infec Immun. 23:1979;502-508.
58. Gordon D.L., Johnson G.M., Hostetter M.K. J Infec Dis. 154:1986;619-626.
59. Cornacoff J.B., Hebert L.A., Smead W.L., Van Aman M.E., Birmingham D.J., Waxman F.J. J Clin Invest. 71:1983;236-247.
60. Szebeni J., Alving C.R., Savay S., Hunter A.C., Moghimi S.M. Proc Int Symp Control Rel Bioact Mater. 28:2001;. Abstract 5094.
61. Rodrigueza W.V., Phillips M.C., Williams K.J. Adv Drug Deliv Rev. 32:1998;31-34.
62. Moghimi S.M. Biochim Biophys Acta. 1590:2002;131-139.
63. Schiffelers R.M., Storm G., Bkker-Woudenberg I.A.J.M. Pharmaceut Res. 18:2001;780-787.
64. Abe T., Sakamoto K., Kamohara H., Hirano Y.I., Kuwahara N., Ogawa M. Int J Cancer. 74:1997;245-250.
65. Vermehren C., Kiebler T., Hylander I., Callisen T.H., Jørgensen K. Biochim Biophys Acta. 1373:1998;27-36.
66. Hoyrup P., Mouritsen O.G., Jørgensen K. Biochim Biophys Acta. 1515:2001;133-143.
67. Davidson J., Jorgensen K., Andersen T.L., Mouritsen O.G. Biochim Biophys Acta. 1609:2003;95-101.
68. Eue I. Int J Cancer. 92:2001;426-433.
69. Hunter A.C., Moghimi S.M. Drug Discov Today. 7:2002;998-1001.
70. Jagannath C., Pai S., Actor J.K., Hunter R.L. J Interferon Cytokine Res. 19:1999;67-76.
71. Hunter R.L., Bennett B. J Immunol. 133:1984;3167-3175.
72. Lloyd J.B. Lloyd J.B., Mason R.W. Biology of the lysosome, subcellular biochemistry, Vol 27. 1996;361-386 Plenum Press, New York.
73. Lloyd J.B. Clin Science. 95:1998;107-110.
74. Washington C., King S.M., Heenan R.K. J Phys Chem. 100:1996;7603-7609.
75. Priev A, Samuni AM, Tirosh O, Barenholz Y. In: Gregoriadis G, McCormack B. Targeting of drugs 6: strategies for stealth therapeutic systems. New York: Plenum Press; 1998. p.147-67.